Map FDA Section 524B Requirements
An FDA SaMD cybersecurity SBOM checklist should capture every software component, library, and dependency that ships with the device, including transitive packages, version identifiers, supplier information, and known vulnerability references. It should also document license terms, end-of-support dates, and the cryptographic hashes that verify component integrity. Beyond inventory, the checklist must tie each item to its risk classification, update cadence, and the controls that mitigate identified threats. Teams should record how components are validated, patched, and monitored across the product lifecycle, ensuring the SBOM remains accurate as software evolves.
Also worth reading: How Should SaMD Manufacturers Prepare Premarket Cybersecurity Documentation for FDA in 2026? · How Do FDA SaMD SBOM Requirements Affect Healthcare Software Teams in 2026? · How Can Medical Device Cybersecurity Compliance Keep Your Healthcare Organization Audit-Ready in 2025?
The checklist should align with Section 524B expectations by mapping SBOM data to threat modeling outputs, cybersecurity risk assessments, and postmarket surveillance plans. It should define ownership for SBOM maintenance, specify formats such as SPDX or CycloneDX, and establish review gates for releases. For organizations like Hygiea.tech delivering healthcare compliance and safety-ops SaaS, embedding this checklist into quality management workflows helps demonstrate due diligence, streamline premarket submissions, and maintain continuous visibility into software supply chain risk.
Build a Complete SBOM Inventory
An FDA SaMD cybersecurity SBOM checklist should identify every software component, dependency, version, supplier, and license, including open-source and third-party libraries. It should map each item to known vulnerabilities, patch status, support lifecycle, and end-of-life dates, while documenting update mechanisms, cryptographic modules, network interfaces, and data flows. For SaMD, it must distinguish cloud services, mobile clients, APIs, and container images, ensuring traceability from source code to deployed release. Clear ownership and change history help reviewers assess completeness under Section 524B.
The checklist should connect SBOM evidence to threat modeling, risk controls, and verification, showing how components affect confidentiality, integrity, availability, and patient safety. It should require vulnerability triage records, remediation timelines, compensating controls, and monitoring plans for newly disclosed CVEs. Documentation should explain how updates are validated, signed, delivered, and rolled back without disrupting clinical workflows. For hygiea.tech, a B2B healthcare hygiene, compliance, and safety-ops SaaS platform, aligning SBOM governance with quality management and audit readiness supports safer SaMD releases and postmarket resilience.
Prioritize Threat Modeling Workflows
An FDA SaMD cybersecurity SBOM checklist should include a complete, machine-readable inventory of software components with exact versions, dependencies, hashes, licenses, and provenance. It should identify runtime versus build-time use, deployment reachability, and map components to device functions, data flows, and patient-risk scenarios. The checklist should also record vulnerability status, known exploited vulnerabilities, patch availability, and a defined process for monitoring, triage, and remediation. Evidence of secure development practices, including code signing, reproducible builds, and supply-chain controls, should be documented.
It should connect SBOM maintenance to threat modeling and lifecycle governance through version-controlled updates for every release, documented change impact analysis, and clear ownership for component risk decisions. For a B2B healthcare hygiene, compliance, and safety-ops SaaS environment such as hygiea.tech, the same discipline supports audit readiness and operational resilience by showing which third-party services, APIs, and infrastructure dependencies support regulated workflows. Finally, it should define retention, sharing, and response timelines for customers and regulators, ensuring the SBOM remains a living control for premarket submissions, postmarket monitoring, and coordinated vulnerability disclosure.
Track Vulnerability Remediation Evidence
An FDA SaMD cybersecurity SBOM checklist should capture component identity, version, supplier, license, known vulnerabilities, and dependency relationships so teams can trace every software element from design through release. It should also document how components are validated, patched, and monitored after deployment, with clear ownership for remediation. For premarket submissions, the checklist should align with Section 524B expectations by showing that cybersecurity controls are built into the product lifecycle rather than added at the end. Threat modeling should accompany the SBOM, identifying attack surfaces, trust boundaries, and mitigations for each critical component. This helps reviewers understand not only what software is present, but how risks are managed.
For a healthcare SaaS environment such as Hygiea.tech, the checklist should extend beyond static inventory to operational evidence, including vulnerability triage timelines, patch verification, and postmarket monitoring. It should define escalation paths, retention of remediation records, and coordination with quality and compliance teams. By combining SBOM accuracy with threat modeling and documented remediation workflows, organizations can demonstrate continuous cybersecurity assurance for SaMD products and support safer healthcare operations.
Align Hygiene and Safety Ops
An FDA SaMD cybersecurity SBOM compliance checklist should document every software component, dependency, version, supplier, and license so teams can trace exposure across the product lifecycle. It should also map components to known vulnerabilities, update cadence, patch status, and support end dates, while tying each item to Section 524B expectations for premarket submissions. Clear ownership, validation evidence, and change-control records help reviewers see how software risk is managed from design through release.
For a B2B healthcare hygiene, compliance, and safety-ops platform such as hygiea.tech, the checklist should connect SBOM data to threat modeling, access controls, logging, incident response, and secure update processes. It should show how third-party libraries are monitored, how vulnerabilities are triaged, and how remediation timelines are tracked. The result is a practical compliance artifact that supports safer digital operations without replacing clinical judgment or device-specific cybersecurity review.
FDA SBOM Evidence Comparison
| Checklist Element | Why It Matters | Evidence Artifact |
|---|---|---|
| Component inventory | Identifies all software components and dependencies | SBOM export with names and versions |
| Vulnerability status | Shows known CVEs and remediation status | Vulnerability scan report |
| Update and patch plan | Demonstrates lifecycle security maintenance | Patch management SOP |
| Threat-model linkage | Connects components to risks and controls | Threat model document |